Published date: 18 March 2022

This notice was replaced on 14 April 2023

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 14 April 2023)

Awarded contract - This means that the contract has been awarded to a supplier.


Contract summary

Industry

  • Market research services - 79310000

Location of contract

E14 4PU

Value of contract

£50,000

Procurement reference

CF-0714500D0O000000rwimUAA1

Published date

18 March 2022

Closing date

4 November 2021

Closing time

12pm

Contract start date

1 December 2021

Contract end date

29 April 2022

Contract type

Service contract

Procedure type

Call-off from a framework agreement

A mini-competition or direct purchase from a pre-established framework agreement.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The Medicines and Healthcare products Regulatory Agency (MHRA) requires research to provide the patient and public perception of risk related to breast implants. The outputs in conjunction with existing evidence may inform regulatory decision making on the use of breast implants on the UK market.

There is a need to conduct research due to a rise in reported cases of Breast Implant Associated Anaplastic Large Cell Lymphoma known as BIA-ALCL and other symptoms related to breast implants.

The aim of the research is to gauge public perception of acceptable levels of risk amongst specific subject groups.

In all cases, we are interested in people who are pre and post-surgery. We want to determine how attitudes to risk may vary amongst different groups and at various different stages in their journey.

We require a research organisation/Supplier to manage and deliver these research services, taking responsibility for (not an exhaustive list): participant recruitment including the payment of any incentive payments; sampling; questionnaire and script/topic guide design; fieldwork; analysis; and producing the reporting and data outputs. We consider a range of research methodologies could be effective in this delivery. The appointed Supplier should be experienced in handling research projects on sensitive subjects (especially in the healthcare sector) and with potentially hard-to-recruit participants.

We consider a range and/or combination of qualitative and quantitative research methodologies could be effective in this delivery, such as face-to-face, telephone, and online approaches including panels, tripod interviews, focus groups, and depth interviews. Research organisations/tenderers are requested to provide details of appropriate methodologies/approaches that ensure that the research aims and objectives are met.

Call-Off Contract from CCS DPS RM6018.

More information

Links

Award information

Awarded date

16 March 2022

Contract start date

1 December 2021

Contract end date

29 April 2022

Total value of contract

£47,638

This contract was awarded to 1 supplier.

ESRO Limited T/A Revealing Reality

Address

The Ballroom, Maritime House, Grafton Square, Clapham, London, SW4 0JW

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Purchasing

Address

10 South Colonnade, Canary Wharf
London
E14 4PU
GB

Email

purchasing@mhra.gov.uk